Diodes Incorporated <DIOD.O>: Truist Securities cuts target price to $133 from $139
DIOD•Related News
SAB Biotherapeutics Q2 FY26 net loss widens to $22.5 million; R&D expenses more than doubled to $16.2 million
SABS•
Kenvue misses quarterly estimates as inflation, tariffs squeeze margins
KVUE•
E.L.F. Beauty, Inc. <ELF.N>: Raymond James raises target price to $100 from $87
ELF•
Encompass Health <EHC.N>: BofA Global Research raises price objective to $153.00 from $150.00
EHC•
Sabre beats Q2 revenue and adjusted EBITDA estimates, raises 2026 outlook
SABR•